Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation with percutaneous hepatic perfusion (PHP) delivers chemotherapy in high doses directly to the liver and is a potentially ef...
Saved in:
| Main Authors: | Lindsey Teal, Jeffrey Yorio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2021/8870334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
by: Vidhya Karivedu, et al.
Published: (2019-01-01) -
Hepatic Regeneration in Fulminant Hepatic Failure
by: Gerald Y Minuk
Published: (1993-01-01) -
Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
by: Vidhya Karivedu, et al.
Published: (2019-01-01) -
Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
Published: (2020-10-01) -
Fulminant Hepatic Failure Secondary to Primary Hepatic Angiosarcoma
by: Ayokunle T. Abegunde, et al.
Published: (2015-01-01)